Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Growth and Development × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 229 Carboplatin 217 Cisplatin 135 Bevacizumab 91 Topotecan 69 Gemcitabine 68 liposomal doxorubicin 57 pembrolizumab 49 Docetaxel 48 Cyclophosphamide 48 Doxorubicin 43 Radiotherapy 41 Taxes 40 Surveys and Questionnaires 40 Filgrastim 37 Brachytherapy 34 olaparib 33 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 24 Drug Therapy 24 Blood Specimen Collection 23 human papillomavirus vaccine, L1 type 16, 18 22 niraparib 21 Peripheral Blood Stem Cell Transplantation 21 Nivolumab 20 Hyperthermic Intraperitoneal Chemotherapy 20 Etoposide 19 atezolizumab 18 Pemetrexed 18 Oxaliplatin 18 Early Intervention, Educational 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05414097 2024-04-15

FIND

UNC Lineberger Comprehensive Cancer Center

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡